Clinical trial
Quantitative Pharmacogenomics of the Anticoagulant Response to Warfarin in Healthy Subjects
NCT01520402 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Quantitative Pharmacogenomics of the Anticoagulant Response to Warfarin in Healthy Subjects
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2009
- Completion date
- May 31, 2011
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy